Metronidazole Injection USP, RTU, 500 mg/100mL in Viaflex Plus Container, Baxter, Deerfield, IL 60015, NDC 0338-1055-48
Published July 10, 2013 · Recall initiated: May 21, 2013
Summary
FDA records drug Class II recall D-629-2013, published July 10, 2013 and initiated May 21, 2013. Recalling firm: Baxter Healthcare Corp.; Status: Terminated; Reported quantity: 172,296 units; Lot: Lot #: P280123, P280123A, Exp 2/14. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the result of a manufacturing issue which occurred during the sealing of the closure assembly at the administration port.
What to do
Voluntary: Firm initiated · Letter
Get an email if METRONIDAZOLE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- METRONIDAZOLE
- Manufacturer
- Baxter Healthcare Corp.
- Distributor
- Nationwide & Puerto Rico
- Lot
- Lot #: P280123, P280123A, Exp 2/14
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMetronidazole Injection USP, 500 mg per 100 mL (5 mg/mL), 100mL Sterile Single Dose Container bag, Rx only,June 1, 2016
- FDASodium Chloride Injection, USP, a) Product code 2B1301- 50 mL in Viaflex Container Quad Pack (NDCJuly 10, 2013
- FDAPrempro (Conjugated Estrogen/Medroxyprogesterone Acetate) tablets 0.625 mg/2.5 mg, 1 blister card containingJuly 10, 2013
- FDALidocaine Hydrochloride and 5% Dextrose Injection, USP, 2g VIAFLEX Plus Plastic Container, 500mL, Rx Only,July 10, 2013
- FDAPrempro (Conjugated Estrogen/Medroxyprogesterone Acetate) tablets 0.625 mg/5.0 mg, 1 blister card containingJuly 10, 2013
- FDAHeparin Sodium and 0.9% Sodium Chloride Injection, a) Product code 2B0944, 2000 USP Units, Viaflex PlusJuly 10, 2013
Questions about this recall
Was Metronidazole Injection USP, RTU, 500 mg/100mL in Viaflex Plus Container, Baxter, Deerfield, IL 60015, NDC 0338-1055-48 recalled?
Yes. FDA published recall D-629-2013 on July 10, 2013. Reported hazard: Lack of Assurance of Sterility: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the result of a manufacturing issue which occurred during the sealing of the closure assembly at the administration port.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: METRONIDAZOLE.